本页面由Tiger Trade Technology Pte. Ltd.提供服务

Zevra Therapeutics

11.65
-0.2200-1.85%
成交量:78.45万
成交额:919.64万
市值:6.89亿
市盈率:12.13
高:12.01
开:11.98
低:11.45
收:11.87
52周最高:15.04
52周最低:7.16
股本:5,911.49万
流通股本:5,385.99万
量比:0.89
换手率:1.46%
股息:- -
股息率:- -
每股收益(TTM):0.9602
每股收益(LYR):1.35
净资产收益率:34.80%
总资产收益率:8.74%
市净率:3.16
市盈率(LYR):8.63

数据加载中...

2026/08/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/14

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/06

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/05

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/08/05

重要事件披露

Form 8-K - Current report
2026/07/31

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/07/09

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/06/05

重要事件披露

Form 8-K - Current report
2026/05/11

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/05/06

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/05/06

重要事件披露

Form 8-K - Current report
2026/05/06

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/03/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/16

重要事件披露

Form 8-K - Current report
2026/03/09

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/03/09

重要事件披露

Form 8-K - Current report
2026/03/09

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/02/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/30

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/30

关联方拟减持公告

Form 144 - Report of proposed sale of securities